Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

3 buys whatever the EU referendum result: AstraZeneca plc, YouGov plc and Cobham plc

These three stocks look set to perform well whether Leave or Remain win today’s vote: AstraZeneca plc (LON: AZN), YouGov plc (LON: YOU) and Cobham plc (LON: COB).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So, the EU referendum is finally upon us and many investors may be wondering which stocks are set to perform well given a Remain or Leave victory. Certainly, there are many examples of potential winners given either result, but there are also stocks that could be set to record stunning share price gains whether the UK stays in or quits the EU.

One such is AstraZeneca (LSE: AZN). Its status as an international pharmaceutical company means that it’s more dependent on the ups and downs of the patent cycle rather than the booms and busts of the UK economy. And on the patent front it appears to be making strong progress with its acquisition strategy improving AstraZeneca’s treatment pipeline so that it’s on track to return to positive earnings growth over the medium term.

Furthermore, AstraZeneca is unlikely to slow down its pace of acquisitions, with the company having excellent cash flow, which affords it tremendous financial firepower. For example, in the last three years AstraZeneca’s free cash flow has averaged $4.9bn per annum and so it seems able to afford to spend further in order to beef up its pipeline. And with that cash flow supporting a yield of 5%, the company’s income potential remains upbeat – especially while interest rates are at rock bottom.

Headline grabber

Also offering upbeat future prospects whatever the EU referendum result is YouGov (LSE: YOU). Clearly, it has been in the headlines a lot more than usual recently, with its polling segment offering up predictions of whether Leave or Remain will win the vote. This could provide a boost to YouGov’s earnings in the short run and with the company expected to increase its net profit by 11% this year and by a further 13% next year, it seems to be performing well.

In fact, YouGov has an excellent track record of earnings growth, with its bottom line rising in each of the last five financial years. And with its shares trading on a price-to-earnings growth (PEG) ratio of just 1.6, they seem to offer a wide margin of safety for long-term investors. Therefore, whether the UK leaves or stays in the EU, YouGov seems to be a sound buy.

Contract wins

Meanwhile, aerospace company Cobham (LSE: COB) has today announced that it has been awarded a contract by Airbus to provide satellite communications to single-aisle and long-range aircraft families. The contract could be worth as much as $200m and will see aircraft being fitted with the communications technology from 2018 onwards. It’s the second major contract Cobham has won with Airbus in the last two months.

Clearly, Cobham has experienced a challenging period of late and its bottom line is due to fall by 22% this year. However, with it being geographically highly diversified and more reliant on the global economy than the UK economy, its return to growth next year seems to be less dependent on the outcome of today’s referendum than is the case for a number of its index peers. And with it trading on a price-to-earnings (P/E) ratio of 11.9, it seems to offer a sufficiently wide margin of safety to merit investment at the present time.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

Investors can target £22,491 in passive income from £20,000 in this FTSE dividend gem

This ultra-high-yielding FTSE gem’s dividend is forecast to rise even higher in the coming years, driving high passive income flows…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

After Qatar cuts its stake in Sainsbury’s, is its share price now a great short-term risk/long-term reward play?

Sainsbury’s share price slid after Qatar cut its stake, but with a new activist investor at the helm, does it…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

British billionaire has 61% of his hedge fund in these 3 S&P 500 stocks 

This world-class hedge fund manager only invests in companies with extremely wide moats. Which three S&P 500 stocks currently dominate…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

I’m targeting £11,363 a year in retirement from £20,000 in Aviva shares!

£20,000 invested in Aviva shares could make me £11,363 in annual retirement income from this FTSE 100 passive income investment…

Read more »

Investing Articles

Down 20% but 15% annual earnings growth forecast — is BT’s share price a bargain or a bust going into 2026?

BT’s share price has fallen a long way since July, but analysts forecast strong earnings growth in the coming years,…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

I asked ChatGPT to produce an unbeatable second income ISA portfolio and it said… 

Harvey Jones asked artificial intelligence to come up with a portfolio of dividend-paying stocks to produce a second income for…

Read more »

Investing Articles

Worried about a 2026 stock market slump? This ISA investment pays 4%+ with low risk

This type of low-risk fund could be an option to consider for ISA investors who are waiting for better stock…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

2 British income shares to consider before the Christmas boom

Our writer scoured historical market data to uncover which income shares typically do well in the run up to Christmas.…

Read more »